TibaRay is a groundbreaking brand dedicated to revolutionizing cancer radiation treatment and bringing hope to patients worldwide. With a mission to cure all types and stages of cancer, TibaRay has developed the most significant innovation in cancer radiation treatment technology in over 60 years. Radiation therapy plays a vital role in cancer treatment, with more than 60% of patients requiring it.

However, the core technology behind radiation therapy has remained largely unchanged for over six decades until now. TibaRay's PHASER technology addresses the need for speed by providing instantaneous treatment that is 400 times faster. It also offers motion-freezing precision targeting and exquisite 3-D dose sculpting.

Additionally, TibaRay's pioneering eXactFLASH technology delivers highly conformal 3D dose sculpting with unparalleled speed, activating the sought-after FLASH effect. Powered by revolutionary inventions in linear accelerator and radio frequency power technologies, TibaRay's breakthroughs in beam intensity modulation and dose shaping are the result of collaborations with esteemed professors in Radiation Oncology, Medical Physics, and Accelerator Science from Stanford and SLAC National Accelerator Lab. Positioned for success, TibaRay is honored to be a StartX company, joining a community of experienced entrepreneurs, industry experts, tenured Stanford professors, and well-funded growth-stage start-ups.

With 92% of all StartX companies still growing or acquired, TibaRay is poised to make a significant impact in the fight against cancer. If you're interested in supporting TibaRay as an investor or joining their dedicated team, or if you simply want to learn more about their mission, don't hesitate to contact them. TibaRay is located in Santa Clara, California, and is committed to creating breakthrough technologies that will change the lives of cancer patients around the world